After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Enovis Corp is $1.65B. A total of 1.14 million shares were traded on the day, compared to an average of 826.29K shares.
In the most recent transaction, PRYOR DANIEL A sold 999 shares of ENOV for 27.20 per share on Dec 09 ’25. After the transaction, the Former EVP, Strategy & Bus Dev now owns 0 company shares. In a previous transaction on Dec 09 ’25, PRYOR DANIEL A sold 666 shares at 27.21 per share. ENOV shares that Former EVP, Strategy & Bus Dev owns now total 160,449.
Among the insiders who bought shares, KLECKNER JOHN acquired of 2,468 shares on Nov 25 ’25 at a per-share price of $30.32. This resulted in the Principal Accounting Officer holding 12,302 shares of ENOV after the transaction. In another insider transaction, McDonald Damien bought 6,457 shares at $30.97 per share on Sep 11 ’25. Company shares held by the Chief Executive Officer now total 102,753.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ENOV has a high of $49.38 and a low of $25.47.
As of this writing, ENOV has an earnings estimate of $0.82 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.86 per share and a lower estimate of $0.79. The company reported an EPS of $0.98 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ENOV’s latest balance sheet shows that the firm has $680.25M in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $1.02B in liabilities at the time. Its Book Value Per Share was $35.33, while its Total Shareholder’s Equity was $4.66B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
